Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00063973
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2003-07-08
Brief Title:
Cilengitide in Treating Children With Refractory Primary Brain Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Childhood Visual Pathway and Hypothalamic Glioma |
| Childhood Central Nervous System Germ Cell Tumor |
| Childhood Choroid Plexus Tumor |
| Childhood Craniopharyngioma |
| Childhood Ependymoblastoma |
| Childhood Grade I Meningioma |
| Childhood Grade II Meningioma |
| Childhood Grade III Meningioma |
| Childhood High-grade Cerebellar Astrocytoma |
| Childhood High-grade Cerebral Astrocytoma |
| Childhood Infratentorial Ependymoma |
| Childhood Low-grade Cerebellar Astrocytoma |
| Childhood Low-grade Cerebral Astrocytoma |
| Childhood Medulloepithelioma |
| Childhood Mixed Glioma |
| Childhood Oligodendroglioma |
| Childhood Supratentorial Ependymoma |
| Recurrent Childhood Brain Stem Glioma |
| Recurrent Childhood Brain Tumor |
| Recurrent Childhood Cerebellar Astrocytoma |
| Recurrent Childhood Cerebral Astrocytoma |
| Recurrent Childhood Ependymoma |
| Recurrent Childhood Medulloblastoma |
| Recurrent Childhood Pineoblastoma |
| Recurrent Childhood Subependymal Giant Cell Astrocytoma |
| Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor |
Keywords: